International Developments in Atherosclerosis Disease Research Using Precision Medicine (1994–2024): A Bibliometric Analysis

  • Danang Prasetyaning Amukti universitas ahmad dahlan
  • Lalu Muhammad Irham Universitas Ahmad Dahlan
  • Sugiyarto Surono Universitas Ahmad Dahlan
  • Wirawan Adikusuma University of Muhammadiyah Mataram
  • Riat El Khair Department Medical, Dr. Sardjito Central General Hospital, Yogyakarta 55281, Indonesia
  • Rizky Gustinanda Universitas Ahmad Dahlan
  • Dilpreet Singh Chandigarh University
  • Rockie Chong University of California
  • Ilker Ates Ankara University
  • Daraporn Rungprai Silpakorn University
DOI: https://doi.org/10.5937/scriptamed56-53992

Sažetak


Cardiovascular disease has risen to the leading cause of global death. Atherosclerosis (AS) is an important contributor to the development of cardiovascular disease, which is involved in the formation of atheromatous plaques on the walls of arteries, resulting in arterial stenosis. In the past two decades, the treatment approach has shifted from conventional methods to precision medicine, which aims to tailor medical interventions based on individual patient characteristics, including genetic information, biomarkers and environmental factors. A literature search of precision medicine research on atherosclerosis from 1994 to 2024 was conducted using the Scopus database. VOSViewer v.1.6.16 and Biblioshiny software programs were used to perform bibliometric analysis. Between 1994 and 2024, 482 documents were published from 299 different sources, with an average document age of 3.68 years and an average of 24.52 citations per document. The total number of authors involved was 3.141, with 40 of them writing the documents individually. Collaboration between authors was very prominent, with an average of 7.89 authors per document and 29.46 % of the documents involving international collaboration. The types of documents published were also diverse, including 187 articles, 1 book, 15 book chapters, 11 conference papers, 33 editorials, 1 erratum, 4 letters, 8 notes, 219 reviews and 3 short surveys. Global trends in precision medicine for atherosclerosis research from 1994 to 2024 showed that the field has undergone significant development. Precision medicine has great potential to improve the care of patients with atherosclerosis through a more personalised and data-driven approach. To maximise its benefits globally, international collaboration, investment in technology and education are needed to overcome existing barriers. Thus, precision medicine can bring significant changes to the research and treatment of atherosclerosis in the future.

Reference

Tian W, Zhang T, Wang X, Zhang J, Ju J, Xu H. Global research trends in atherosclerosis: A bibliometric and visualized study. Front Cardiovasc Med. 2022 Aug 23;9:956482. doi: 10.3389/fcvm.2022.956482.

Ruilope LM, Chagas AC, Brandão AA, Gómez-Berroterán R, Alcalá JJ, Paris JV, et al. Hypertension in Latin America: Current perspectives on trends and characteristics. Hipertens Riesgo Vasc. 2017 Jan-Mar;34(1):50-6. doi: 10.1016/j.hipert.2016.11.005.

Hu SS; Writing Committee of the Report on Cardiovascular Health and Diseases in China. Epidemiology and current management of cardiovascular disease in China. J Geriatr Cardiol. 2024 Apr 28;21(4):387-406. doi: 10.26599/1671-5411.2024.04.001.

Saepudin M, Pranaka RN, Umboh HH, Wardoyo S. Risk factors associated with rabies incidence in rabies endemic areas in West Kalimantan. Germs. 2022 Dec 31;12(4):472-7. doi: 10.18683/germs.2022.1353.

Chan YH, Ramji DP. Atherosclerosis: Pathogenesis and key cellular processes, current and emerging therapies, key challenges, and future research directions. Methods Mol Biol. 2022;2419:3-19. doi: 10.1007/978-1-0716-1924-7_1.

Nguyen TK, Paone S, Chan E, Poon IKH, Baxter AA, Thomas SR, Hulett MD. Heparanase: A novel therapeutic target for the treatment of atherosclerosis. Cells. 2022 Oct 12;11(20):3198. doi: 10.3390/cells11203198.

McCurdy S, Baumer Y, Toulmin E, Lee BH, Boisvert WA. Macrophage-specific expression of IL-37 in hyperlipidemic mice attenuates atherosclerosis. J Immunol. 2017 Nov 15;199(10):3604-13. doi: 10.4049/jimmunol.1601907.

Silva DVTD, Baião DDS, Ferreira VF, Paschoalin VMF. Betanin as a multipath oxidative stress and inflammation modulator: a beetroot pigment with protective effects on cardiovascular disease pathogenesis. Crit Rev Food Sci Nutr. 2022;62(2):539-54. doi: 10.1080/10408398.2020.1822277.

Luca M, Luca A. Oxidative stress-related endothelial damage in vascular depression and vascular cognitive impairment: beneficial effects of aerobic physical exercise. Oxid Med Cell Longev. 2019 Dec 20;2019:8067045. doi: 10.1155/2019/8067045.

Bruikman CS, Stoekenbroek RM, Hovingh GK, Kastelein JP. New drugs for atherosclerosis. Can J Cardiol. 2017 Mar;33(3):350-7. doi: 10.1016/j.cjca.2016.09.010.

Kocyigit D, Gurses KM, Tokgozoglu L. Anti-inflammatory therapy in atherosclerosis. Front Biosci (Landmark Ed). 2020 Jan 1;25(2):242-69. doi: 10.2741/4805.

Xu J, Tan Y, Zhang M. [Medical imaging in tumor precision medicine: opportunities and challenges]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(5):455-61. Chinese. doi: 10.3785/j.issn.1008-9292.2017.10.01.

Berkowitz CL, Mosconi L, Scheyer O, Rahman A, Hristov H, Isaacson RS. Precision medicine for Alzheimer’s disease prevention. Healthcare (Basel). 2018 Jul 13;6(3):82. doi: 10.3390/healthcare6030082.

Chakraborty S, Kannihalli A, Mohanty A, Ray S. The promises of proteomics and metabolomics for unravelling the mechanism and side effect landscape of beta-adrenoceptor antagonists in cardiovascular therapeutics. OMICS. 2023 Mar;27(3):87-92. doi: 10.1089/omi.2023.0003.

McGonigle IV. The collective nature of personalized medicine. Genet Res (Camb). 2016 Jan 21;98:e3. doi: 10.1017/S0016672315000270.

Roda A, Michelini E, Caliceti C, Guardigli M, Mirasoli M, Simoni P. Advanced bioanalytics for precision medicine. Anal Bioanal Chem. 2018 Jan;410(3):669-77. doi: 10.1007/s00216-017-0660-8.

Wan Y, Shen J, Hong Y, Liu J, Shi T, Cai J. Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022. Front Oncol. 2023 Jun 23;13:1181164. doi: 10.3389/fonc.2023.1181164.

Luo D, Liang W, Ma B, Xue D. Global trends of indocyanine green fluorescence navigation in laparoscopic cholecystectomy: bibliometrics and knowledge atlas analysis. Surg Endosc. 2022 Sep;36(9):6419-31. doi: 10.1007/s00464-021-08988-9.

Liu R, Gao D, Yang N, Qiao Y, Zhang Z, Zuo M. Global research and scientific publications on PND between 1969 and 2022: A bibliometric analysis. Aging Med (Milton). 2024 Jun 14;7(3):368-83. doi: 10.1002/agm2.12310.

Ullah R, Asghar I, Griffiths MG. An integrated methodology for bibliometric analysis: a case study of internet of things in healthcare applications. Sensors (Basel). 2022 Dec 21;23(1):67. doi: 10.3390/s23010067.

Khairi SSM, Bakar MAA, Alias MA, Bakar SA, Liong CY, Rosli N, et al. Deep learning on histopathology images for breast cancer classification: a bibliometric analysis. Healthcare (Basel). 2021 Dec 22;10(1):10. doi: 10.3390/healthcare10010010.

Gong Z, Guo Y, Liu X, Ai K, Li W, Li J. Bibliometric analysis of research trends on tuina manipulation for neck pain treatment over the past 10 years. J Pain Res. 2023 Jun 15;16:2063-77. doi: 10.2147/JPR.S410603.

Zheng J, Hou M, Liu L, Wang X. Knowledge structure and emerging trends of telerehabilitation in recent 20 years: a bibliometric analysis via CiteSpace. Front Public Health. 2022 Jun 20;10:904855. doi: 10.3389/fpubh.2022.904855.

Ju Y, Long H, Zhao P, Xu P, Sun L, Bao Y, et al. The top 100 cited studies on bacterial persisters: A bibliometric analysis. Front Pharmacol. 2022 Sep 13;13:1001861. doi: 10.3389/fphar.2022.1001861.

Wu Q, Sun Y, Luo Z, Li X, Wen Y, Shi Y, e al. Application and development of zero-valent iron (ZVI)-based materials for environmental remediation: A scientometric and visualization analysis. Environ Res. 2024 Jan 15;241:117659. doi: 10.1016/j.envres.2023.117659.

Canario Guzmán JA, Espinal R, Báez J, Melgen RE, Rosario PAP, Mendoza ER. Ethical challenges for international collaborative research partnerships in the context of the Zika outbreak in the Dominican Republic: a qualitative case study. Health Res Policy Syst. 2017 Sep 25;15(1):82. doi: 10.1186/s12961-017-0246-0.

Lin H, Zhang M, Hu M, Zhang Y, Jiang W, Tang W, et al. Emerging applications of single-cell profiling in precision medicine of atherosclerosis. J Transl Med. 2024 Jan 23;22(1):97. doi: 10.1186/s12967-023-04629-y.

Weber C, Habenicht AJR, von Hundelshausen P. Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond. Eur Heart J. 2023 Aug 1;44(29):2672-81. doi: 10.1093/eurheartj/ehad304.

Zhang JH, Ni SY, Tan YT, Luo J, Wang SC. A bibliometric analysis of PIN1 and cell death. Front Cell Dev Biol. 2022 Oct 31;10:1043725. doi: 10.3389/fcell.2022.1043725.

McGinn RJ, Von Stein EL, Summers Stromberg JE, Li Y. Precision medicine in epilepsy. Prog Mol Biol Transl Sci. 2022;190(1):147-88. doi: 10.1016/bs.pmbts.2022.04.001.

Georgakopoulou VE, Lempesis IG, Sklapani P, Trakas N, Spandidos DA. Precision medicine for respiratory diseases: A current viewpoint. Med Int (Lond). 2024 Apr 12;4(4):31. doi: 10.3892/mi.2024.155.

Wrzeszczynski KO, Felice V, Shah M, Rahman S, Emde AK, Jobanputra V, et al. Whole genome sequencing-based discovery of structural variants in glioblastoma. Methods Mol Biol. 2018;1741:1-29. doi: 10.1007/978-1-4939-7659-1_1.

Donlin LT, Park SH, Giannopoulou E, Ivovic A, Park-Min KH, Siegel RM, Ivashkiv LB. Insights into rheumatic diseases from next-generation sequencing. Nat Rev Rheumatol. 2019 Jun;15(6):327-39. doi: 10.1038/s41584-019-0217-7.

Mizzi D, Allely CS, Zarb F, Mercer CE. Implementing supplementary breast cancer screening in women with dense breasts: Insights from European radiographers and radiologists. Radiography (Lond). 2024 May;30(3):908-19. doi: 10.1016/j.radi.2024.04.003.

Objavljeno
2025/04/30
Broj časopisa
Vol. 56 Br. 2 (2025): Mar-Apr
Rubrika
Aktuelna tema
Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).